April 2024
1. MONSTER JL, Kemp LJ, Busslinger GA, Vliem MJ, et al
   Cell division-dependent dissemination following E-cadherin loss underlies initiation of diffuse-type gastric cancer.
   J Pathol. 2024 Apr 4. doi: 10.1002/path.6277.
   

   >> Share

   
   March 2024
2. DUAN S, Sawyer TW, Witten BL, Song H, et al
   Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
   J Pathol. 2024;262:362-376.
   

   >> Share

   
   June 2023
3. CHOI S, Kim H, Heo YJ, Kang SY, et al
   PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
   J Pathol. 2023 Jun 21. doi: 10.1002/path.6134.
   

   >> Share

   
   
4. ZHANG J, Chen B, Wang Y, Liu X, et al
   The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer.
   J Pathol. 2023 Jun 5. doi: 10.1002/path.6091.
   

   >> Share

   
   May 2023
5. GOLDENRING JR
   Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer.
   J Pathol. 2023 May 5. doi: 10.1002/path.6089.
   

   >> Share

   
   April 2023
6. YING L, Liu P, Ding Z, Wray-McCann G, et al
   Anti-CD40L therapy prevents the formation of precursor lesions to gastric B-cell MALT lymphoma in a mouse model.
   J Pathol. 2023;259:402-414.
   

   >> Share

   
   February 2023
7. KONDO A, Shinozaki-Ushiku A, Rokutan H, Kunita A, et al
   Loss of Viral Genome with Altered Immune Microenvironment During Tumour Progression of Epstein-Barr Virus-Associated Gastric Carcinoma.
   J Pathol. 2023 Feb 18. doi: 10.1002/path.6067.
   

   >> Share

   
   January 2023
8. KUMAGAI K, Shimizu T, Nikaido M, Hirano T, et al
   On the origin of gastric tumours: analysis of a case with intramucosal gastric carcinoma and oxyntic gland adenoma.
   J Pathol. 2023 Jan 10. doi: 10.1002/path.6050.
   

   >> Share

   
   December 2022
9. HALMAI NB, Carvajal-Carmona LG
   Advancing gastric cancer precision medicine with novel genomic screens.
   J Pathol. 2022 Dec 21. doi: 10.1002/path.6046.
   

   >> Share

   
   October 2022
10. KANEKO K, Zaitoun AM, Letley DP, Rhead JL, et al
    The active form of Helicobacter pylori vacuolating cytotoxin induces decay-accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa.
    J Pathol. 2022;258:199-209.
    

    >> Share

    
    August 2022
11. NAMIKAWA K, Tanaka N, Ota Y, Takamatsu M, et al
    Genomic features of Helicobacter pylori-naive diffuse-type gastric cancer.
    J Pathol. 2022 Aug 11. doi: 10.1002/path.6000.
    

    >> Share

    
    June 2022
12. LIU B, Katoh H, Komura D, Yamamoto A, et al
    Functional genomics screening identifies aspartyl-tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers.
    J Pathol. 2022 Jun 13. doi: 10.1002/path.5980.
    

    >> Share

    
    
13. FLINNER N, Gretser S, Quaas A, Bankov K, et al
    Deep learning based on hematoxylin-eosin staining outperforms immunohistochemistry in predicting molecular subtypes of gastric adenocarcinoma.
    J Pathol. 2022;257:218-226.
    

    >> Share

    
    September 2021
14. GROSSER B, Gluckstein MI, Dhillon C, Schiele S, et al
    Stroma Areactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes.
    J Pathol. 2021 Sep 27. doi: 10.1002/path.5810.
    

    >> Share

    
    April 2021
15. DIXON K, Brew T, Farnell D, Godwin TD, et al
    Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing.
    J Pathol. 2021 Apr 2. doi: 10.1002/path.5675.
    

    >> Share

    
    January 2021
16. KOH J, Nam SK, Kwak Y, Kim G, et al
    Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
    J Pathol. 2021;253:94-105.
    

    >> Share

    
    November 2020
17. GENG Q, Lao J, Zuo X, Chen S, et al
    Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
    J Pathol. 2020;252:263-273.
    

    >> Share

    
    October 2020
18. SHANG W, Wang Y, Liang X, Li T, et al
    SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.
    J Pathol. 2020 Oct 12. doi: 10.1002/path.5568.
    

    >> Share

    
    July 2020
19. RIERA KM, Jang B, Min J, Roland JT, et al
    Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa.
    J Pathol. 2020;251:336-347.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share